Kathleen Wilson, M.D.

Director, Cytogenomic Microarray Analysis Laboratory; Chair, UT Southwestern Medical School Admissions Committee; Co-director, Medical School Genetics Course

  • Pathology


Dr. Kathleen S. Wilson is the Director of the Cytogenomic Microarray Analysis (CMA) laboratory in the Genetic Diagnostics Laboratories. She established the first CMA Laboratory for patient diagnostics in North Texas in 2008, bringing this technologically advanced form of high resolution chromosome analysis for clinical care to U.T. Southwestern and the North Texas region. She completed her undergraduate education at Amherst College and graduated with honors in 1986. She received her medical degree in 1991 from The University of Texas Southwestern Medical Center at Dallas. She subsequently completed pathology residency and genetics fellowship training also at UT Southwestern. 

Dr. Wilson is a faculty member in the Department of Pathology and the McDermott (Genetics) Center for Human Growth and Development. She is board-certified by the American Board of Pathology (ABP) in Clinical Pathology and the American Board of Medical Genetics (ABMG) in Clinical Cytogenetics. She is also a fellow of the College of American Pathologists (CAP) and the American College of Medical Genetics (ACMG).

She has served on the Cytogenetics Resource Committee (CyRC) of the CAP and ACMG for over a decade and was involved in setting national policy for cytogenetics and molecular cytogenomics by developing accreditation guidelines and issuing proficiency testing. She has served as chair of the Economics of Genetic Services Committee for ACMG and has also been an active participant nationally in policy related to reimbursement for high complexity genetic testing.  She is currently involved in multiple medical school administrative and educational activities in her roles as Chair of the UT Southwestern Medical School Admissions Committee and Co-Director of the Medical Student Genetics Course.

Dr. Wilson’s interest and experience in molecular genetics and genomics have been longstanding with recent publications in The Journal of Pediatric Hematology Oncology and Pediatric and Developmental Pathology, and book chapters in Abeloff: Clinical Oncology, 4th ed., Clinical Laboratory Hematology, 3rd ed. and Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease, 5th ed. 

Dr. Wilson has won teaching awards and has been actively involved in the teaching and mentorship of medical and graduate students, house staff, and junior faculty for over twenty-five years.

Education & Training
  • Fellowship - UT Southwestern Medical Center (1995-1997), Cytogenetics
  • Fellowship - UT Southwestern Medical Center (1994-1995), Hematopathology
  • Residency - UT Southwestern Medical Center (1992-1994), Pathology
  • Internship - UT Southwestern Medical Center (1991-1992), Pathology
  • Medical School - UT Southwestern Medical School (1986-1991)
Professional Associations & Affiliations
  • Texas Medical Association (1991)
  • Dallas County Medical Society (1991)
  • American Medical Association (1991)
  • College of American Pathologists (1993)
  • American College of Medical Genetics (2002)
Honors & Awards
  • Guide to America's Top Pathologists 2007, Consumers' Research Council of America (2007-present)
  • Outstanding Teacher in Pathology 2007, UT Southwestern Class of 2009
  • Small Group Teaching Award in Pathology 2007, UT Southwestern Class of 2009
  • Doximity Recognition 2017, Top M.D. by Consumers Checkbook
  • Outstanding Teacher in Genetics: Pre-Clinical Teaching Award 2012, UT Southwestern Class of 2015
  • Aston L. Clarke Research Fellowship 1985, UT Southwestern Medical Center at Dallas
  • Amherst College: Graduation with Honors 1986, B.A., magna cum laude
  • Guide to America's Top Physicians 2004, Consumers' Research Council of America (2004-present)
  • Favorite Teacher Recognition in Pathology 2005, UT Southwestern Class of 2007
Books & Publications
  • My research interests are focused on the clinical utilization of multiple genetic diagnostic technologies (next generation sequencing, cytogenomic microarray analysis, fluorescence in situ hybridization and conventional cytogenetics) in an integrated approach to elucidate the pathogenetic events of both constitutional and acquired (neoplastic) disorders.